Moderna will supply COVID-19 vaccines made in Laval by fall 2025 – Montreal Gazette

LAVAL A new Moderna plant in Laval will be able to supply COVID-19 vaccines for the fall 2025 vaccination campaign, the company said Friday during an official visit to mark the end of construction work at the messenger RNA production facility.

We apologize, but this video has failed to load.

The $250-million Laval plant should produce about 100 million doses of RNA vaccines annually, able to provide vaccines to all Canadians, said Modernas chief operating and quality officer, Jerh Collins.

This advertisement has not loaded yet, but your article continues below.

The factory will be able to do much more than produce vaccines against COVID-19, noted the minister of Innovation, Science and Industry, Franois-Philippe Champagne, at a news conference.

Moderna is not just about COVID-19. This is a range of vaccines that we will be able to produce at home. There are even vaccines potentially for cancer.

Quebecs economy minister, Pierre Fitzgibbon, emphasized the project makes it possible to reduce Canadas dependence on foreign vaccine production.

He said Modernas new project will serve as a calling card to attract other projects in the pharmaceutical sector to Quebec.

There are international pharmaceutical companies that are looking at what is happening, the talent that there is at McGill, that there is at Universit de Montral, among others. I think it will create quite significant momentum for life sciences.

Recommended from Editorial

This advertisement has not loaded yet, but your article continues below.

Read more from the original source:

Moderna will supply COVID-19 vaccines made in Laval by fall 2025 - Montreal Gazette